CD8 controls T cell cross-reactivity

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4625-4632

  Wooldridge, Linda ^a   Laugel, Bruno ^a   Ekeruche, Julia ^a   Clement, Mathew ^a   Van Den Berg, Hugo A ^b   Price, David A ^a   Sewell, Andrew K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CROSS REACTION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANTIGEN PRESENTATION; CELL LINE; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SEPARATION; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL;

EID: 78049493197     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001480     Document Type: Article

References (42)

1. Davis, M. M., J. J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16:523-544.
2. Rudolph, M. G., and I. A. Wilson. 2002. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14:52-65.
3. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24:419-466.
4. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 1999. A direct estimate of the human alphabeta T cell receptor diversity. Science 286:958-961.
5. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395-404.
6. Wilson, D. B., D. H. Wilson, K. Schroder, C. Pinilla, S. Blondelle, R. A. Houghten, and K. C. Garcia. 2004. Specificity and degeneracy of T cells. Mol. Immunol. 40:1047-1055.
7. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8alpha (alpha) and HLA-A2. Nature 387:630-634.
8. Wang, R., K. Natarajan, and D. H. Margulies. 2009. Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position. J. Immunol. 183:2554-2564.
9. Zamoyska, R. 1998. CD4 and CD8: modulators of T-cell receptor recognition of antigen and of immune responses? Curr. Opin. Immunol. 10:82-87.
10. Zamoyska, R., P. Derham, S. D. Gorman, P. von Hoegen, J. B. Bolen, A. Veillette, and J. R. Parnes. 1989. Inability of CD8 alpha′ polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo. Nature 342:278-281.
11. lck complexes. J. Exp. Med. 194:1485-1495.
12. Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosineprotein kinase p56lck. Cell 55:301-308.
13. Purbhoo, M. A., J. M. Boulter, D. A. Price, A. L. Vuidepot, C. S. Hourigan, P. R. Dunbar, K. Olson, S. J. Dawson, R. E. Phillips, B. K. Jakobsen, et al. 2001. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J. Biol. Chem. 276:32786-32792.
14. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353-356.
15. Wooldridge, L., H. A. van den Berg, M. Glick, E. Gostick, B. Laugel, S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, and A. K. Sewell. 2005. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 280:27491-27501.
16. Rabinowitz, J. D., C. Beeson, D. S. Lyons, M. M. Davis, and H. M. McConnell. 1996. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA 93:1401-1405.
17. Kersh, G. J., E. N. Kersh, D. H. Fremont, and P. M. Allen. 1998. High-and lowpotency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9:817-826.
18. van den Berg, H. A., and D. A. Rand. 2007. Quantitative theories of T-cell responsiveness. Immunol. Rev. 216:81-92.
19. Aleksic, M., O. Dushek, H. Zhang, E. Shenderov, J. L. Chen, V. Cerundolo, D. Coombs, and P. A. van der Merwe. 2010. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity 32:163-174.
20. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282:23799-23810.
21. van den Berg, H. A., L. Wooldridge, B. Laugel, and A. K. Sewell. 2007. Coreceptor CD8-driven modulation of T cell antigen receptor specificity. J. Theor. Biol. 249:395-408.
22. Gakamsky, D. M., I. F. Luescher, A. Pramanik, R. B. Kopito, F. Lemonnier, H. Vogel, R. Rigler, and I. Pecht. 2005. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 89:2121-2133.
23. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18:255-264.
24. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction: a role for CD8 in distinguishing antigen quality. Immunity 25:203-211.
25. Zal, T., M. A. Zal, and N. R. Gascoigne. 2002. Inhibition of T cell receptorcoreceptor interactions by antagonist ligands visualized by live FRET imaging of the T-hybridoma immunological synapse. Immunity 16:521-534.
26. Wooldridge, L., A. Lissina, J. Vernazza, E. Gostick, B. Laugel, S. L. Hutchinson, F. Mirza, P. R. Dunbar, J. M. Boulter, M. Glick, et al. 2007. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur. J. Immunol. 37:1323-1333.
27. Kan-Mitchell, J., M. Bajcz, K. L. Schaubert, D. A. Price, J. M. Brenchley, T. E. Asher, D. C. Douek, H. L. Ng, O. O. Yang, C. R. Rinaldo, Jr., et al. 2006. Degeneracy and repertoire of the human HIV-1 Gag p17 (77-85) CTL response. J. Immunol. 176:6690-6701.
28. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78.
29. *0201-restricted hTERT (540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Mol. Cancer Ther. 6:2081-2091.
30. Madrenas, J., L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:219-229.
31. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191:335-346.
32. Kerry, S. E., J. Buslepp, L. A. Cramer, R. Maile, L. L. Hensley, A. I. Nielsen, P. Kavathas, B. J. Vilen, E. J. Collins, and J. A. Frelinger. 2003. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. J. Immunol. 171:4493-4503.
33. Wooldridge, L., M. Clement, A. Lissina, E. S. Edwards, K. Ladell, J. Ekeruche, R. E. Hewitt, B. Laugel, E. Gostick, D. K. Cole, et al. 2010. MHC class I molecules with superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs. J. Immunol. 184:3357-3366.
34. Hutchinson, S. L., L. Wooldridge, S. Tafuro, B. Laugel, M. Glick, J. M. Boulter, B. K. Jakobsen, D. A. Price, and A. K. Sewell. 2003. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J. Biol. Chem. 278:24285-24293.
35. Van Laethem, F., S. D. Sarafova, J. H. Park, X. Tai, L. Pobezinsky, T. I. Guinter, S. Adoro, A. Adams, S. O. Sharrow, L. Feigenbaum, and A. Singer. 2007. Deletion of CD4 and CD8 coreceptors permits generation of alphabetaT cells that recognize antigens independently of the MHC. Immunity 27:735-750.
36. + T cells. J. Exp. Med. 197:1709-1719.
37. Maile, R., C. A. Siler, S. E. Kerry, K. E. Midkiff, E. J. Collins, and J. A. Frelinger. 2005. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. J. Immunol. 174:619-627.
38. Gangadharan, D., and H. Cheroutre. 2004. The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR co-receptor CD8alphabeta. Curr. Opin. Immunol. 16:264-270.
39. Daniels, M. A., L. Devine, J. D. Miller, J. M. Moser, A. E. Lukacher, J. D. Altman, P. Kavathas, K. A. Hogquist, and S. C. Jameson. 2001. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15:1051-1061.
40. Moody, A. M., D. Chui, P. A. Reche, J. J. Priatel, J. D. Marth, and E. L. Reinherz. 2001. Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding. Cell 107:501-512.
41. Daniels, M. A., K. A. Hogquist, and S. C. Jameson. 2002. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat. Immunol. 3:903-910.
42. Park, J. H., S. Adoro, P. J. Lucas, S. D. Sarafova, A. S. Alag, L. L. Doan, B. Erman, X. Liu, W. Ellmeier, R. Bosselut, et al. 2007. 'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the selfspecificity of the TCR. Nat. Immunol. 8:1049-1059.